Table 3.
Distribution of adverse drug reactions in emergency departments at MEREAFaPS hospitals, 2010–2011, according to ATC level 1
| Therapeutic category (level 1 ATC) | n (%a) | Serious (%b per each ATC) |
|---|---|---|
| J. Anti-infectives for systemic use | 2,333 (21.0) | 36.1 |
| B. Blood and blood-forming organs | 2,028 (18.3) | 52.4 |
| N. Nervous system | 1,943 (17.5) | 53.8 |
| C. Cardiovascular system | 1,445 (13.0) | 62.7 |
| M. Musculoskeletal system | 1,367 (12.3) | 41.6 |
| A. Alimentary tract and metabolism | 986 (8.9) | 67.7 |
| R. Respiratory system | 254 (2.3) | 28.0 |
| L. Antineoplastic and immunomodulating agents | 177 (1.6) | 59.3 |
| G. Genitourinary system and sex hormones | 146 (1.3) | 31.5 |
| H. Systemic hormonal preparations excluding sex hormones and insulins | 142 (1.3) | 45.8 |
| S. Sensory organs | 79 (0.7) | 7.6 |
| D. Dermatologicals | 78 (0.7) | 14.1 |
| V. Various | 76 (0.7) | 68.4 |
| P. Antiparasitic products insecticides and repellents | 31 (0.3) | 29.0 |
Notes:
a
Column percentage;
b
row percentage.
Abbreviations: ATC, Anatomical Therapeutic Chemical classification; MEREAFaPS, Monitoring of ADRs in ED.